Trials / Completed
CompletedNCT01933321
Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Autologous cell therapy in patients with ALS can stimulate neuroplasticity, modifying the neurodegenerative process and stops the clinical progression of disease.
Detailed description
There is no more extensive information
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Intrathecal autologous stem cell | Mobilization and collection of stem cells for intravenous and intrathecal administration |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2014-01-01
- Completion
- 2014-06-01
- First posted
- 2013-09-02
- Last updated
- 2015-04-03
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01933321. Inclusion in this directory is not an endorsement.